Cygnos Biotech, LLC

Miami, FL

UEI
PXYDY5CQJDM3
CAGE
8WQ76
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
10650 SW 137th St, Miami, FL 33176, USA
Website
cygnosbiotech.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Cygnos Biotech, LLC's 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
The purpose of this small business innovation research (sbir) phase II contract is to show efficacy of anti-viral… Contract · W911SR26CA003 ACC Aberdeen Proving Ground $1,397,164
Research to create a class of agnostic drugs targeting the host to assist in fighting off a broad spectrum of viral… Contract · W911SR25C0013 ACC Aberdeen Proving Ground $204,493

SBA capabilities narrative

CYGNOS BioTech, LLC is a U.S.-based small business biotechnology company specializing in the development of virus-agnostic, host-directed antiviral biologics for veterinary and future human use, aligned with One Health and biodefense priorities. The company applies protein biologic engineering, advanced analytical characterization, and AI-assisted structural modeling to enable safe, manufacturable antiviral candidates. CYGNOS leverages an integrated network of academic, CRO, and cGMP manufacturing partners to advance programs from early discovery through preclinical development, regulatory engagement, and pilot clinical evaluation.

Quick answers

What is Cygnos Biotech, LLC's UEI?

Cygnos Biotech, LLC's Unique Entity ID (UEI) in SAM.gov is PXYDY5CQJDM3.

What is Cygnos Biotech, LLC's CAGE code?

Cygnos Biotech, LLC's CAGE code is 8WQ76.

What is Cygnos Biotech, LLC's primary NAICS code?

Cygnos Biotech, LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Cygnos Biotech, LLC located?

Cygnos Biotech, LLC's physical address in SAM.gov is 10650 SW 137th St, Miami, FL 33176, USA.

Is Cygnos Biotech, LLC registered in SAM.gov?

Yes. Cygnos Biotech, LLC's SAM.gov registration is active through December 23, 2026.

What is Cygnos Biotech, LLC's most recent federal award?

Cygnos Biotech, LLC's most recent federal contract award is The purpose of this small business innovation research (sbir) phase II contract is to show efficacy of anti-viral… (W911SR26CA003), from ACC Aberdeen Proving Ground, on February 2, 2026.

On GovTribe

See Cygnos Biotech, LLC's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors